comparemela.com

Latest Breaking News On - Avadel lumryz - Page 1 : comparemela.com

Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet (NASDAQ:ALKS)

Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet (NASDAQ:ALKS)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

How to Navigate the Narcolepsy Pharmacotherapy Landscape

Avadel Pharma Down 14% After Jazz Files Lawsuit Against FDA To Overturn Approval Of Lumryz

Shares of Avadel Pharmaceuticals plc (AVDL) are down 14% on Friday after Jazz Pharmaceuticals filed a lawsuit against FDA for approving Avadel's Lumryz, a drug for excessive daytime sleepiness in adult patients with narcolepsy.

Why Avadel Pharmaceuticals (AVDL) Stock Is Trading Lower Premarket Today

Why Avadel Pharmaceuticals (AVDL) Stock Is Trading Lower Premarket Today
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Why Avadel Pharmaceuticals (AVDL) Stock Is Trading Lower Premarket Today - Avadel Pharmaceuticals (NASDAQ:AVDL), Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has filed suit against the FDA for approving Avadel Pharmaceuticals Plc's (NASDAQ: AVDL) Lumryz (sodium oxybate extended-release) for cataplexy or excessive day

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.